2012年国际病毒性肝炎和世界肝病大会6月22号召开希望好消息

StephenW

   6月24日
斯蒂芬Urban教授：Mycrludex的发明者
安德鲁Vaillant博士：REP9AC的发明者
郭海通博士：新CCCDNA形成抑制剂
Trepor教授： - 新的缓释干扰素

10:30 - 12:30	Parallel Session 14: Innovative Therapeutic Approaches		Auditorium
	Moderators:	John E. Tavis	St. Louis
		Alexander J. Thompson	Melbourne
10:30	Therapeutic advances for the management of HDV	Michael P. Manns	Hanover
10:50	Interim report on safety AND efficacy of a new sustained    release IFN (IFN XL) as compared to standard of care	Christian Trépo	Lyon
11:10	IFN-free treatment approaches	Edward J. Gane	Auckland
11:30	Development of novel peptide-based inhibitors that block HBV    entry	Stephan Urban	Heidelberg
11:50	Identification of the Disubstituted Sulfonamide Compounds as    Specific Inhibitors of HBV cccDNA Formation	Haitao Guo	Doylestown
12:05	Restoration of immune function and control of chronic HBV    infection after clearance of serum HBsAg by nucleic acid polymers.	Andrew Vaillant	Montreal

StephenW

会议前课程二：未来在抗乙肝病毒治疗的治疗目标：我们的目标是在乙肝病毒根除吗？礼堂
版主：马西莫Levrero罗马, Michael P. 迈克尔 Hanover
11:30 在HBV 新的药物靶标，斯蒂芬A. Locarnini 北墨尔本
11:50 走向消灭乙肝流行病学角度, 陈定信 台北
12:10 α-干扰素的分子机制抑制乙型肝炎病毒复制的, 劳拉·贝罗尼 罗马
12:30 HBV cccDNA水平和开发新型有效的治疗方法, 马西莫Levrero 罗马
12:50 治愈乙肝是可能吗？需要？蒂莫西·M。Block

13:10讨论

Pre-Conference Course II:    Future therapeutic targets in anti-HBV therapy: can we aim at HBV    eradication?		Auditorium
	Moderators:	Massimo Levrero	Rome
		Michael P. Manns	Hanover
11:30	New drug targets in HBV	Stephen A. Locarnini	North Melbourne
11:50	Towards the eradication of    hepatitis B: epidemiology perspective	Ding-Shinn Chen	Taipei
12:10	Molecular mechanism of IFN-α    suppresses HBV replication	Laura Belloni	Rome
12:30	HBV cccDNA and the development    of novel effective therapeutics	Massimo Levrero	Rome
12:50	Is a cure for hepatitis B    possible? Is it needed?	Timothy M. Block	Doylestown
13:10	Discussion

cwy121

回复 StephenW 的帖子

mingbai

希望带来好消息

挚友888888

等好消息